{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:14:17Z","timestamp":1759565657791},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,7,8]],"date-time":"2005-07-08T00:00:00Z","timestamp":1120780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1007\/s00262-005-0017-6","type":"journal-article","created":{"date-parts":[[2005,7,7]],"date-time":"2005-07-07T18:19:26Z","timestamp":1120760366000},"page":"363-374","source":"Crossref","is-referenced-by-count":12,"title":["Structure and function of ETAA16: a novel cell surface antigen in Ewing\u2019s tumours"],"prefix":"10.1007","volume":"55","author":[{"given":"A.","family":"Borowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Dirksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Lixin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. L.","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"G\u00f6bel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. M.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,7,8]]},"reference":[{"key":"17_CR1","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/1097-0142(19910401)67:7<1886::AID-CNCR2820670712>3.0.CO;2-U","volume":"67","author":"IM Ambros","year":"1991","unstructured":"Ambros IM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer-Kuntschik M (1991) MIC2 is a specific marker for Ewing\u2019s sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing\u2019s sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 67:1886","journal-title":"Cancer"},{"key":"17_CR2","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1038\/sj.onc.1202129","volume":"17","author":"A Arvand","year":"1998","unstructured":"Arvand A, Bastians H, Welford SM, Thompson AD, Ruderman JV, Denny CT (1998) EWS\/FLI1 up regulates mE2-C, a cyclin-selective ubiquitin conjugating enzyme involved in cyclin B destruction. Oncogene 17:2039","journal-title":"Oncogene"},{"key":"17_CR3","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1038\/sj.onc.1204598","volume":"20","author":"A Arvand","year":"2001","unstructured":"Arvand A, Denny CT (2001) Biology of EWS\/ETS fusions in Ewing\u2019s family tumors. Oncogene 20:5747","journal-title":"Oncogene"},{"key":"17_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0171-2985(99)80029-1","volume":"200","author":"A Borowski","year":"1999","unstructured":"Borowski A, van Valen F, et al. (1999) Monomorphic HLA class I-(non-A, non-B) expression on Ewing\u2019s tumor cell lines, modulation by TNF-\u03b1 and IFN-\u03b3. Immunobiology 200:1","journal-title":"Immunobiology"},{"key":"17_CR5","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1128\/MCB.15.8.4623","volume":"15","author":"BS Braun","year":"1995","unstructured":"Braun BS, Frieden R, Lessnick SL, May WA, Denny CT (1995) Identification of target genes for the Ewing\u2019s sarcoma EWS\/FLI fusion protein by representational difference analysis. Mol Cell Biol 15:4623","journal-title":"Mol Cell Biol"},{"key":"17_CR6","first-page":"507","volume":"127","author":"AO Cavazzana","year":"1987","unstructured":"Cavazzana AO, Miser JS, Jefferson J, Triche TJ (1987) Experimental evidence for a neural origin of Ewing\u2019s sarcoma of bone. Am J Pathol 127:507","journal-title":"Am J Pathol"},{"key":"17_CR7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/abio.1987.9999","volume":"162","author":"P Chomzynski","year":"1987","unstructured":"Chomzynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156","journal-title":"Anal Biochem"},{"key":"17_CR8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1023\/A:1009231110030","volume":"6","author":"C Dixkens","year":"1998","unstructured":"Dixkens C, Posseckert G, Keller T, Hameister H (1998) Structural analysis of the amplified IFN-beta and DHFR genes in a Chinese hamster ovary cell line using multicolour FISH analysis. Chromosome Res 6:329","journal-title":"Chromosome Res"},{"key":"17_CR9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/01913120120194","volume":"25","author":"A Franchi","year":"2001","unstructured":"Franchi A, Pasquinelli G, et al. (2001) Immunohistochemical and ultrastructural investigation of neural differentiation in Ewing sarcoma\/PNET of bone and soft tissues. Ultrastruct Pathol 25:219","journal-title":"Ultrastruct Pathol"},{"key":"17_CR10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00001622-199507000-00011","volume":"7","author":"L Granowetter","year":"1995","unstructured":"Granowetter L (1995) Ewing\u2019s sarcoma and extracranial peripheral neuroectodermal tumors. Curr Opin Oncol 7:355","journal-title":"Curr Opin Oncol"},{"key":"17_CR11","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/13854","volume":"23","author":"KB Hahm","year":"1999","unstructured":"Hahm KB, Cho K, et al. (1999) Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein. Nat Genet 23:222","journal-title":"Nat Genet"},{"key":"17_CR12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/cne.20059","volume":"472","author":"J Jankowski","year":"2004","unstructured":"Jankowski J, Holst MI, Liebig C, Oberdick J, Baader SL (2004) Engrailed-2 negatively regulates the onset of perinatal Purkinje cell differentiation. J Comp Neurol 472:87","journal-title":"J Comp Neurol"},{"key":"17_CR13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00001622-199407000-00011","volume":"6","author":"HF J\u00fcrgens","year":"1994","unstructured":"J\u00fcrgens HF (1994) Ewing\u2019s sarcoma and peripheral primitive neuroectodermal tumor. Curr Opin Oncol 6:391","journal-title":"Curr Opin Oncol"},{"key":"17_CR14","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/modpathol.3880213","volume":"13","author":"K Kato","year":"2000","unstructured":"Kato K, Arai K, et al. (2000) Epithelioid leiomyosarcoma in a non-immunocompromised infant: additional differential diagnosis of pediatric \u201cRound Cell Tumors\u201d. Mod Pathol 13:1156","journal-title":"Mod Pathol"},{"key":"17_CR15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0092-8674(86)90762-2","volume":"44","author":"M Kozak","year":"1986","unstructured":"Kozak M (1986) Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44:283","journal-title":"Cell"},{"key":"17_CR16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s003359900171","volume":"7","author":"M Kozak","year":"1996","unstructured":"Kozak M (1996) Interpreting cDNA sequences: some insights from studies on translation. Mamm Genome 7:563","journal-title":"Mamm Genome"},{"key":"17_CR17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0022-2836(82)90515-0","volume":"157","author":"J Kyte","year":"1982","unstructured":"Kyte J, Doolittle RF (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157:105","journal-title":"J Mol Biol"},{"key":"17_CR18","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35057062","volume":"409","author":"ES Lander","year":"2001","unstructured":"Lander ES, Linton LM et al. (2001) Initial sequencing and analysis of the human genome. Nature 409:860","journal-title":"Nature"},{"key":"17_CR19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s000660050059","volume":"175","author":"HJ Laws","year":"1999","unstructured":"Laws HJ, Burdach S, et al. (1999) Multimodality diagnostics and megatherapy in poor prognosis Ewing\u2019s tumor patients. a single-center report. Strahlenther Onkol 175:488","journal-title":"Strahlenther Onkol"},{"key":"17_CR20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ng1297-495","volume":"17","author":"WA May","year":"1997","unstructured":"May WA, Arvand A, Thompson AD, Braun BS, Wright M, Denny CT (1997) EWS\/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic. Nat Genet 17:495","journal-title":"Nat Genet"},{"key":"17_CR21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0065-2776(00)75006-1","volume":"75","author":"CJ Melief","year":"2000","unstructured":"Melief CJ, Toes RE, Medema JP, van der Burg SH, Ossendorp F, Offringa R (2000) Strategies for immunotherapy of cancer. Adv Immunol 75:235","journal-title":"Adv Immunol"},{"key":"17_CR22","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/ijc.2910630522","volume":"63","author":"A Pagani","year":"1995","unstructured":"Pagani A, Fischer-Colbrie R, Eder U, Pellin A, Llombart-Bosch A, Bussolati G (1995) Neural and mesenchymal differentiations in Ewing\u2019s sarcoma cell lines. Morphological, immunophenotypic, molecular biological and cytogenetic evidence. Int J Cancer 63:738","journal-title":"Int J Cancer"},{"key":"17_CR23","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1200\/JCO.2001.19.6.1818","volume":"19","author":"M Paulussen","year":"2001","unstructured":"Paulussen M, Ahrens S, et al. (2001) Localized Ewing tumor of bone:final results of the cooperative Ewing\u2019s Sarcoma Study CESS 86. J Clin Oncol 19:1818","journal-title":"J Clin Oncol"},{"key":"17_CR24","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1038\/sj.onc.1204044","volume":"19","author":"P Remy","year":"2000","unstructured":"Remy P, Baltzinger M (2000) The Ets-transcription factor family in embryonic development: lessons from the amphibian and bird. Oncogene 19:6417","journal-title":"Oncogene"},{"key":"17_CR25","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1200\/JCO.2003.06.041","volume":"21","author":"A Ribas","year":"2003","unstructured":"Ribas A, Butterfield LH, Glaspy JA, Economou JS (2003) Current developments in cancer vaccines and cellular immunotherapy. J Clin Oncol 21:2415","journal-title":"J Clin Oncol"},{"key":"17_CR26","volume-title":"Molecular cloning: a laboratory manual, 2nd edn","author":"J Sambrook","year":"1989","unstructured":"Sambrook J, Maniatis T, Fritsch EF (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbour Laboratory Press, New York"},{"key":"17_CR27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00428-001-0558-9","volume":"440","author":"KL Schaefer","year":"2002","unstructured":"Schaefer KL, Wai DH, et al. (2002) Characterization of the malignant melanoma of soft-parts cell line GG-62 by expression analysis using DNA microarrays. Virchows Arch 440:476","journal-title":"Virchows Arch"},{"key":"17_CR28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF01525643","volume":"38","author":"LR Shi","year":"1994","unstructured":"Shi LR, Eichelbauer D, Borchard F, Jurgens H, Gobel U, Schneider EM (1994) Specificity and function of monoclonal antibodies directed against Ewing sarcoma cells. Cancer Immunol Immunother 38:208","journal-title":"Cancer Immunol Immunother"},{"key":"17_CR29","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1182\/blood.V72.5.1639.1639","volume":"72","author":"IC Slaper-Cortenbach","year":"1988","unstructured":"Slaper-Cortenbach IC, Admiraal LG, Kerr JM, van Leeuwen EF, von dem Borne AE, Tetteroo PA (1988) Flow-cytometric detection of terminal deoxynucleotidyl transferase and other intracellular antigens in combination with membrane antigens in acute lymphatic leukemias. Blood 72:1639","journal-title":"Blood"},{"key":"17_CR30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1006\/geno.2000.6408","volume":"71","author":"N Spieker","year":"2001","unstructured":"Spieker N, van Sluis P, et al. (2001) The MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32. Genomics 71:214","journal-title":"Genomics"},{"key":"17_CR31","doi-asserted-by":"crossref","first-page":"8213","DOI":"10.1158\/0008-5472.CAN-03-4059","volume":"64","author":"MS Staege","year":"2004","unstructured":"Staege MS, Hutter C, et al. (2004) DNA Microarrays reveal relationship of ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets. Cancer Res 64:8213","journal-title":"Cancer Res"},{"key":"17_CR32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/10425179809105209","volume":"9","author":"CA Stratakis","year":"1998","unstructured":"Stratakis CA, Taymans SE (1998) Structure of the gene coding for calcineurin B (PPP3R1) and mapping to D2S358-D2S1778 (chromosomal region 2p15). DNA Seq 9:227","journal-title":"DNA Seq"},{"key":"17_CR33","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.iy.10.040192.003153","volume":"10","author":"JL Urban","year":"1992","unstructured":"Urban JL, Schreiber H (1992) Tumor Antigens. Annu Rev Immunol 10:617","journal-title":"Annu Rev Immunol"},{"key":"17_CR34","doi-asserted-by":"crossref","unstructured":"van Valen F (1999) Ewing\u2019s sarcoma family of tumors. In: Masters JRW, Palsson B (eds), Human cell culture, vol. 1. Kluwer, Dordrecht pp 55\u201385","DOI":"10.1007\/0-306-46872-7_3"},{"key":"17_CR35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0925-4773(99)00272-5","volume":"91","author":"V Vlaeminck-Guillem","year":"2000","unstructured":"Vlaeminck-Guillem V, Carrere S, Dewitte F, Stehelin D, Desbiens X, Duterque-Coquillaud M (2000) The Ets family member Erg gene is expressed in mesodermal tissues and neural crests at fundamental steps during mouse embryogenesis. Mech Dev 91:331","journal-title":"Mech Dev"},{"key":"17_CR36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/gcc.10153","volume":"36","author":"G Watanabe","year":"2003","unstructured":"Watanabe G, Nishimori H, et al. (2003) Induction of tenascin-C by tumor-specific EWS-ETS fusion genes. Genes Chromosomes Cancer 36:224","journal-title":"Genes Chromosomes Cancer"},{"key":"17_CR37","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/sj.onc.1204133","volume":"20","author":"JP Zwerner","year":"2001","unstructured":"Zwerner JP, May WA (2001) PDGF-C is an EWS\/FLI induced transforming growth factor in Ewing family tumors. Oncogene 20:626","journal-title":"Oncogene"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-005-0017-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-005-0017-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-005-0017-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T05:25:20Z","timestamp":1586323520000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-005-0017-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,8]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["17"],"URL":"https:\/\/doi.org\/10.1007\/s00262-005-0017-6","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,8]]}}}